This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2008 Feb;32(2):201-2.

doi: 10.1016/j.leukres.2007.06.020. Epub 2007 Aug 6.

Will cyclopentenyl cytosine (CPEC) ever have a future in the clinic?

Chris van Bree, André B P van Kuilenburg

PMID: 17681375
DOI: 10.1016/j.leukres.2007.06.020

Editorial

Will cyclopentenyl cytosine (CPEC) ever have a future in the clinic?

Chris van Bree et al. Leuk Res. 2008 Feb.

. 2008 Feb;32(2):201-2.

doi: 10.1016/j.leukres.2007.06.020. Epub 2007 Aug 6.

Authors

Chris van Bree, André B P van Kuilenburg

PMID: 17681375
DOI: 10.1016/j.leukres.2007.06.020

No abstract available

PubMed Disclaimer

Comment on

Limited antitumor-effect associated with toxicity of the experimental cytotoxic drug cyclopentenyl cytosine in NOD/scid mice with acute lymphoblastic leukemia.
Schimmel KJ, Nijmeijer BA, van Schie ML, Falkenburg JH, Guchelaar HJ. Schimmel KJ, et al. Leuk Res. 2007 Nov;31(11):1545-51. doi: 10.1016/j.leukres.2007.03.022. Epub 2007 Apr 24. Leuk Res. 2007. PMID: 17459472

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science